As peripheral deiodinase activity is increased in MCT8 deficiency, oral administration of T3 and T4 results in aggravation of the peripheral thyrotoxicosis, without improvement of the neurodevelopment [19]. The gene discussed is SLC16A2; the disease is thyrotoxicosis.